Related references
Note: Only part of the references are listed.Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tahmineh Kandelouei et al.
MEDIATORS OF INFLAMMATION (2022)
The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials
Seyyed Mostafa Arabi et al.
INFLAMMOPHARMACOLOGY (2022)
Placebo Response to Oral Administration in Osteoarthritis Clinical Trials and Its Associated Factors A Model-Based Meta-analysis
Xin Wen et al.
JAMA NETWORK OPEN (2022)
Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition
Alexander R. van Rosendael et al.
JAMA CARDIOLOGY (2021)
Aspirin for the Primary Prevention of Cardiovascular Disease A Review of the Literature and Considerations for Clinical Practice
Jonathan D. Cicci et al.
CARDIOLOGY IN REVIEW (2020)
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Walter Masson et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability
Hiroyuki Jinnouchi et al.
ATHEROSCLEROSIS (2020)
Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography
Donghee Han et al.
JAMA NETWORK OPEN (2020)
Statins and C-reactive protein: in silico evidence on direct interaction
Neda Shakour et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Clinical significance of non-culprit plaque regression following acute coronary syndrome: A serial intravascular ultrasound study
Hirohisa Endo et al.
JOURNAL OF CARDIOLOGY (2019)
Association of high sensitive C-reactive protein with coronary heart disease: a Mendelian randomization study
Qian Zhuang et al.
BMC MEDICAL GENETICS (2019)
Statin Use in the US for Secondary Prevention of Cardiovascular Disease Remains Suboptimal
Quyen Ngo-Metzger et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2019)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (vol 140, pg e563, 2019)
Donna K. Arnett et al.
CIRCULATION (2019)
Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis
Sirwan K. L. Darweesh et al.
ALZHEIMERS & DEMENTIA (2018)
Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice
Amir Avan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
C-Reactive Protein in Atherothrombosis and Angiogenesis
Lina Badimon et al.
FRONTIERS IN IMMUNOLOGY (2018)
Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis
Miao Yun Xia et al.
ENDOCRINE (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Resistant Atherosclerosis The Need for Monitoring of Plaque Burden
J. David Spence et al.
STROKE (2017)
Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study
Jiannan Dai et al.
CORONARY ARTERY DISEASE (2017)
Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial)
Tadateru Takayama et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Clinical relevance for lowering C-reactive protein with statins
Jose Carlos Arevalo-Lorido
ANNALS OF MEDICINE (2016)
Effects of 4 Statins on Regression of Coronary Plaque in Acute Coronary Syndrome
Kensuke Matsushita et al.
CIRCULATION JOURNAL (2016)
Intensive statin therapy stabilizes C-reactive protein, but not chemokine in stable coronary artery disease treated with an everolimus-eluting stent
Hiroaki Sukegawa et al.
CORONARY ARTERY DISEASE (2016)
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients The GLAGOV Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effect of Statin Treatment on Modifying Plaque Composition A Double-Blind, Randomized Study
Seung-Jung Park et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Meta-analysis Comparing the Effects of Rosuvastatin Versus Atorvastatin on Regression of Coronary Atherosclerotic Plaques
Cheng Qian et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies
Maciej Banach et al.
BMC MEDICINE (2015)
C-Reactive Protein: Clinical and Epidemiological Perspectives
Juan Salazar et al.
CARDIOLOGY RESEARCH AND PRACTICE (2014)
Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials
Fabrizio D'Ascenzo et al.
ATHEROSCLEROSIS (2013)
Intensive-Dose Atorvastatin Regimen Halts Progression of Atherosclerotic Plaques in New-onset Unstable Angina With Borderline Vulnerable Plaque Lesions
Xin Zhang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis
Tsuyoshi Nozue et al.
AMERICAN HEART JOURNAL (2012)
Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen A Phase IIb Randomized, Placebo-Controlled Trial
Paul M. Ridker et al.
CIRCULATION (2012)
Effect of pitavastatin treatment on changes of plaque volume and composition according to the reduction of high-sensitivity C-reactive protein levels
Young Joon Hong et al.
JOURNAL OF CARDIOLOGY (2012)
Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques
Suxia Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapy
James E. McLaren et al.
PROGRESS IN LIPID RESEARCH (2011)
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
Richard Kones
DRUG DESIGN DEVELOPMENT AND THERAPY (2011)
A basic introduction to fixed-effect and random-effects models for meta-analysis
Michael Borenstein et al.
RESEARCH SYNTHESIS METHODS (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Effects of Statin Treatments on Coronary Plaques Assessed by Volumetric Virtual Histology Intravascular Ultrasound Analysis
Myeong-Ki Hong et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome A Multicenter Randomized Trial Evaluated by Volumetric Intravascular Ultrasound Using Pitavastatin Versus Atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] Study)
Takafumi Hiro et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
The Effects of Rosuvastatin on Plaque Regression in Patients Who Have a Mild to Moderate Degree of Coronary Stenosis With Vulnerable Plaque
Young Joon Hong et al.
Korean Circulation Journal (2009)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Randomized evaluation of atorvastatin in patients with coronary heart disease - A serial intravascular ultrasound study
Takashi Yamada et al.
CIRCULATION JOURNAL (2007)
Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis
Dirk Bose et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
C-reactive protein in atherosclerosis: A causal factor?
Elaine Paffen et al.
CARDIOVASCULAR RESEARCH (2006)
Statins: Potential new indications in inflammatory conditions
Matthias Endres
ATHEROSCLEROSIS SUPPLEMENTS (2006)
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial)
J Dupuis et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
C-reactive protein in atherosclerotic lesions - Its origin and pathophysiological significance
HJ Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound
M Kawasaki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Early statin treatment in patients with acute coronary syndrome - Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH study
S Okazaki et al.
CIRCULATION (2004)
Regression of coronary atherosclerosis by simvastatin - A serial intravascular ultrasound study
LO Jensen et al.
CIRCULATION (2004)
Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue
WJ Jabs et al.
CIRCULATION (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase - An in vitro demonstration in human coronary artery endothelial cells
RS Barua et al.
CIRCULATION (2003)
Share Paper
